Ahead of Rare Disease Day 2026, Optimum is marking the occasion with a brand-new podcast episode featuring Hans Schambye, CEO of BOOST Pharma, Jean-Marie Cuillerot, CMO of Kainova Therapeutics, and Josep Prous, Co‑founder & CSO of CONNECTA.
This episode delves into the critical gaps in therapeutic options for the more than 300 million people living with rare diseases worldwide and explores why this field is rapidly gaining attention from both researchers and investors.
Our guests also share insights into their life‑changing work across brittle bone disease, oncology, and fragile X syndrome, highlighting the breakthroughs that are bringing new hope to patients and families.
","author_name":"Optimum Strategic Communications"}